Sotera Health (SHC) | Financial Analysis & Statements
Sotera Health Company Mid-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
303.4M
Gross Profit
165.9M
54.68%
Operating Income
105.4M
34.73%
Net Income
34.8M
11.48%
EPS (Diluted)
$0.12
Balance Sheet Metrics
Total Assets
3.3B
Total Liabilities
2.7B
Shareholders Equity
606.0M
Debt to Equity
4.38
Cash Flow Metrics
Operating Cash Flow
113.6M
Free Cash Flow
52.4M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Sotera Health Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 1.2B | 1.1B | 1.0B | 1.0B | 931.5M |
| Cost of Goods Sold | 518.1M | 498.1M | 472.1M | 446.7M | 412.8M |
| Gross Profit | 645.5M | 602.3M | 577.2M | 557.0M | 518.7M |
| Gross Margin % | 55.5% | 54.7% | 55.0% | 55.5% | 55.7% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 252.8M | 242.6M | 236.7M | 245.7M | 198.2M |
| Other Operating Expenses | - | - | - | - | - |
| Total Operating Expenses | 252.8M | 242.6M | 236.7M | 245.7M | 198.2M |
| Operating Income | 362.0M | 297.6M | 276.7M | 248.4M | 256.7M |
| Operating Margin % | 31.1% | 27.0% | 26.4% | 24.7% | 27.6% |
| Non-Operating Items | |||||
| Interest Income | - | - | - | - | - |
| Interest Expense | 155.7M | 164.7M | 142.9M | 80.1M | 74.2M |
| Other Non-Operating Income | -58.8M | -19.1M | -27.8M | -411.3M | -6.8M |
| Pre-tax Income | 147.5M | 113.9M | 106.0M | -243.1M | 175.7M |
| Income Tax | 69.6M | 69.5M | 54.7M | -9.5M | 58.6M |
| Effective Tax Rate % | 47.2% | 61.0% | 51.5% | 0.0% | 33.3% |
| Net Income | 77.9M | 44.4M | 51.4M | -233.6M | 117.1M |
| Net Margin % | 6.7% | 4.0% | 4.9% | -23.3% | 12.6% |
| Key Metrics | |||||
| EBITDA | 507.3M | 466.6M | 442.0M | 400.3M | 422.8M |
| EPS (Basic) | $0.27 | $0.16 | $0.18 | $-0.83 | $0.41 |
| EPS (Diluted) | $0.27 | $0.16 | $0.18 | $-0.83 | $0.41 |
| Basic Shares Outstanding | 283956000 | 282784000 | 281008000 | 280096000 | 279228000 |
| Diluted Shares Outstanding | 283956000 | 282784000 | 281008000 | 280096000 | 279228000 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Sotera Health Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 344.6M | 277.2M | 296.4M | 395.2M | 106.9M |
| Short-term Investments | - | - | - | - | - |
| Accounts Receivable | 139.3M | 140.3M | 147.7M | 118.5M | 108.2M |
| Inventory | 54.4M | 49.2M | 48.3M | 37.1M | 54.3M |
| Other Current Assets | 18.1M | 12.3M | 14.4M | 12.8M | 10.7M |
| Total Current Assets | 613.4M | 526.0M | 557.2M | 645.0M | 346.0M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 41.3M | 34.9M | 30.6M | 30.7M | 44.1M |
| Goodwill | 2.5B | 2.5B | 2.6B | 2.7B | 2.8B |
| Intangible Assets | 288.2M | 317.7M | 416.3M | 491.3M | 598.8M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 40.5M | 39.9M | 46.2M | 43.1M | 18.8M |
| Total Non-Current Assets | 2.6B | 2.5B | 2.6B | 2.5B | 2.4B |
| Total Assets | 3.3B | 3.1B | 3.1B | 3.1B | 2.8B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 78.0M | 55.1M | 71.0M | 74.1M | 72.9M |
| Short-term Debt | 23.2M | 22.8M | 19.5M | 206.4M | 10.4M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 1.9M | 4.1M | 414.0K | 3.5M | - |
| Total Current Liabilities | 249.6M | 191.0M | 230.7M | 791.6M | 161.2M |
| Non-Current Liabilities | |||||
| Long-term Debt | 2.3B | 2.3B | 2.3B | 1.8B | 1.8B |
| Deferred Tax Liabilities | 71.1M | 69.5M | 64.5M | 68.0M | 134.5M |
| Other Non-Current Liabilities | 7.4M | 4.4M | 8.9M | 12.8M | 16.3M |
| Total Non-Current Liabilities | 2.4B | 2.5B | 2.5B | 2.0B | 2.0B |
| Total Liabilities | 2.7B | 2.7B | 2.7B | 2.8B | 2.2B |
| Equity | |||||
| Common Stock | 2.9M | 2.9M | 2.9M | 2.9M | 2.9M |
| Retained Earnings | -532.1M | -610.0M | -654.4M | -705.8M | -472.2M |
| Treasury Stock | 17.0M | 23.4M | 27.2M | 29.8M | 33.5M |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 606.0M | 404.9M | 443.7M | 350.2M | 586.1M |
| Key Metrics | |||||
| Total Debt | 2.3B | 2.4B | 2.3B | 2.0B | 1.8B |
| Working Capital | 363.8M | 335.0M | 326.6M | -146.6M | 184.8M |
Balance Sheet Composition
Sotera Health Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 77.9M | 44.4M | 51.4M | -233.6M | 117.1M |
| Depreciation & Amortization | 136.7M | 163.6M | 157.9M | 145.6M | 150.9M |
| Stock-Based Compensation | 30.9M | 36.8M | 32.2M | 21.2M | 13.9M |
| Working Capital Changes | 26.1M | -49.7M | -406.8M | 388.6M | -14.2M |
| Operating Cash Flow | 276.6M | 233.2M | -155.7M | 248.8M | 259.7M |
| Investing Activities | |||||
| Capital Expenditures | -138.0M | -179.1M | -215.0M | -182.4M | -102.2M |
| Acquisitions | - | 0 | 0 | 450.0K | -57.0M |
| Investment Purchases | - | - | - | - | - |
| Investment Sales | - | - | - | - | - |
| Investing Cash Flow | -135.1M | -179.0M | -214.9M | -181.9M | -159.8M |
| Financing Activities | |||||
| Share Repurchases | - | -4.4M | -4.1M | -393.0K | -1.4M |
| Dividends Paid | - | - | - | - | 0 |
| Debt Issuance | 0 | 2.3B | 500.0M | 200.0M | 0 |
| Debt Repayment | -86.1M | -2.3B | -202.5M | 0 | -100.0M |
| Financing Cash Flow | -180.1M | -2.3B | 63.5M | 197.8M | -217.3M |
| Free Cash Flow | 149.2M | 45.1M | -362.7M | 95.6M | 179.4M |
| Net Change in Cash | -38.6M | -2.3B | -307.1M | 264.6M | -117.4M |
Cash Flow Trend
Sotera Health Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
57.70
Forward P/E
14.89
Price to Book
7.31
Price to Sales
3.82
PEG Ratio
0.29
Profitability Ratios
Profit Margin
6.70%
Operating Margin
35.75%
Return on Equity
15.42%
Return on Assets
8.18%
Financial Health
Current Ratio
2.46
Debt to Equity
375.56
Beta
1.88
Per Share Data
EPS (TTM)
$0.27
Book Value per Share
$2.13
Revenue per Share
$4.10
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| SHC | 4.4B | 57.70 | 7.31 | 15.42% | 6.70% | 375.56 |
| Thermo Fisher | 174.6B | 25.84 | 3.31 | 13.52% | 15.15% | 82.91 |
| Danaher | 126.4B | 34.61 | 2.40 | 7.08% | 14.89% | 37.17 |
| Revvity | 9.7B | 45.77 | 1.46 | 3.22% | 8.45% | 46.87 |
| Icon plc | 9.0B | 15.52 | 0.94 | 6.27% | 7.40% | 38.26 |
| Charles River | 8.3B | 681.33 | 2.61 | -4.23% | -3.60% | 81.95 |
Financial data is updated regularly. All figures are in the company's reporting currency.





